Unichem Laboratories Ltd.

Financial

	Unichem Lab	Orchid Pharma	Sequent Scientific
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	41.0 .	n/a	n/a
Number of ANDA's Approved By USFDA	27.0 .	n/a	n/a
R&D as a % of Total Sales	7.38 %	n/a	0.0
Financials
5 yr Average ROE	-2.21 %	-4.13 %	1.28 %
5yr average Equity Multiplier	1.28	1.73	2.12
5yr Average Asset Turnover Ratio	0.42	0.45	0.92
5yr Avg Net Profit Margin	-3.85 %	-7.02 %	0.94 %
Price to Book	1.88	3.5	5.67
P/E	0.0	38.82	330.58
5yr Avg Cash Conversion Cycle	80.33 Days	49.11 Days	55.84 Days
Inventory Days	146.44 Days	112.59 Days	76.26 Days
Days Receivable	128.35 Days	91.49 Days	87.51 Days
Days Payable	225.53 Days	201.52 Days	117.98 Days
5yr Average Interest Coverage Ratio	-0.08	-0.51	2.31
5yr Avg ROCE	-0.47 %	0.51 %	7.29 %
5yr Avg Operating Profit Margin	2.2 %	10.69 %	8.58 %
5 yr average Debt to Equity	0.09	0.49	0.5
5yr CAGR Net Profit	3.21 %	n/a	n/a
5yr Average Return on Assets	-1.68 %	-1.77 %	0.71 %
Shareholdings
Promoter Holding	70.22 %	69.84 %	52.61 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	19.29 %	-20.16 %	-0.41 %
Change in Mutual Fund Holding (3 Yrs)	1.71 %	16.34 %	9.92 %

Business

	Unichem Lab	Orchid Pharma	Sequent Scientific
Product Wise Break-Up	Product Wise Break-Up Formulations 91.7 Bulk Chemicals 8.3 Sterile 0 Oral Formulations 0 Active Pharmaceutical Ingredient 0	Product Wise Break-Up Bulk Chemicals 0 Active Pharmaceutical Ingredient 0 Oral Formulations 76.42 Formulations 0 Sterile 23.58	Product Wise Break-Up Bulk Chemicals 0 Active Pharmaceutical Ingredient (API) 21.13 Oral Formulations 0 Formulations 78.27 Sterile 0 Others 0.6
Location Wise Break-Up	Location Wise Break-Up USA 60.68 India 2.47 Turkey 0 LATAM 0 EM 0 Rest of the World 0 Asia 0 Europe 0 Others 36.85	Location Wise Break-Up Rest of the World 0 EM 0 India 18.32 Europe 0 Turkey 0 LATAM 0 USA 0 Asia 0 Others 81.68	Location Wise Break-Up Rest of the World 34.17 EM 0 India 0 Europe 41.73 Turkey 0 LATAM 0 USA 0 Asia Pacific 24.1